Izrael - hebrajski - Ministry of Health

abic marketing ltd, israel - rivastigmine base - מדבקות - rivastigmine base 9.5 mg / 24 hour - rivastigmine

Izrael - hebrajski - Ministry of Health

teva israel ltd - sunitinib as base - קפסולות - sunitinib as base 12.5 mg - sunitinib

Izrael - hebrajski - Ministry of Health

teva israel ltd - sunitinib as base - קפסולות - sunitinib as base 25 mg - sunitinib

Izrael - hebrajski - Ministry of Health

teva israel ltd - sunitinib as base - קפסולות - sunitinib as base 37.5 mg - sunitinib

Izrael - hebrajski - Ministry of Health

teva israel ltd - sunitinib as base - קפסולות - sunitinib as base 50 mg - sunitinib

Izrael - hebrajski - Ministry of Health

tradis gat ltd - citric acid anhydrous; light magnesium oxide; sodium picosulfate - אבקה להכנת תמיסה - citric acid anhydrous 10.97 g; light magnesium oxide 3.5 g; sodium picosulfate 10 mg - sodium picosulfate, combinations

Izrael - hebrajski - Ministry of Health

dover medical & scientific equipment ltd, israel - factor viii (human); von willebrand factor - אבקה וממס להכנת תמיסה להזרקה - von willebrand factor 1000 iu/vial; factor viii (human) 1000 iu/vial - coagulation factor viii

Izrael - hebrajski - Ministry of Health

dover medical & scientific equipment ltd, israel - factor viii (human); von willebrand factor - אבקה וממס להכנת תמיסה להזרקה - von willebrand factor 500 iu/vial; factor viii (human) 500 iu/vial - coagulation factor viii

Izrael - hebrajski - Ministry of Health

sanofi israel ltd - metronidazole - טבליות מצופות פילם - metronidazole 250 mg - metronidazole - metronidazole - trichomonias, acute intestinal amebiasis. infections due to anaerobic bacteria.

Izrael - hebrajski - Ministry of Health

novartis israel ltd - epoetin alfa - תמיסה להזרקה - epoetin alfa 1000 iu / 0.5 ml - erythropoietin - erythropoietin - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients:- treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis.- treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis. treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy). binocrit can be used to increase the yield of autologous blood from patients in a predonation programme. its use in this indication must be balanced against the reported risk of thromboembolic events. treatment should only be given to non-iron deficient patients with moderate anaemia (haemoglob